Bottom line
What is CLVRX's expense ratio?
CLVRX's expense ratio is 0.19%, or about $19 a year on every $10,000 invested. That is cheaper than 93% of large value funds we track (median 0.81%). It has no front-end sales load.
Updated Jan 27, 2026
CLVRX fee table
| Net expense ratio | 0.19% |
|---|---|
| Gross expense ratio | 0.29% |
| Management fee | 0.24% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.05% |
| Fee waiver / reimbursement | -0.1% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Jan 27, 2026
What CLVRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| CLVRX | $19 | $83 | $153 | $358 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.19% expense ratio costs roughly $11,300 in lost growth, versus about $45,600 for the median large value fund (0.81%).